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Background
The isolation of broadly neutralizing HIV-1 antibodies
that arise during infection has provided insights into the
design of vaccine immunogens capable of eliciting similar
antibody response. The use of HIV-specific sorting probes
resulted in the isolation of antibodies to vulnerable viral
epitopes, such as the CD4-binding site, but the use of such
probes does not explore the subject’s immunoglobulin
repertoire breadth.
Methods
To identify new HIV-1 monoclonal antibodies (mAbs), we
developed a B-cell culture system to isolate and screen
thousands of B cells. Memory B cells were isolated by
negative selection and individually cultured in 384 well
plates with irradiated feeder cells expressing CD40 ligand.
The addition of cytokines IL-2 and IL-21 stimulated prolif-
eration and immunoglobulin secretion.
Results
After 14 days in culture, approximately 35% of the B cell
clones secreted >100 ng/ul of IgG which met the sensitiv-
ity threshold to screen each clone in an automated
micro-neutralization assay. B cell clonal expansion
allowed recovery of the immunoglobulin heavy and light
chains by RT-PCR, with subsequent cloning into expres-
sion vectors and mAb testing against a large panel of
viruses. In one experiment screening approximately 8600
B cells, 9 clones were identified as potential contributors
to the neutralization detected in the patient’s serum. One
of the isolated clones produced mAb VRC22 with 30%
neutralization breadth and moderate potency. Further
studies revealed that VRC22 was sensitive to JRCSF gly-
can mutants N332A and N301A but not N160K. VRC22
utilizes VH4-34 with a single amino acid CDR1 deletion
and a mutation frequency of 7% which is a lower level of
affinity maturation than observed for most known HIV-1
neutralizing antibodies.
Conclusion
This B-cell culture system allows efficient screening of
thousands of individual B cells and the recovery of antigen
specific mAbs. This approach can be used to isolate
human mAbs to diverse pathogens.
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